Dr. Sellers is an internationally recognized authority on clinical psychopharmacology, pharmacogenetics, abuse liability assessment, and substance abuse, having published more than 650 papers. His focus includes accelerating early stage drug development through new methods, optimizing strategies to assess abuse potential of new and re-formulated drugs. He has worked with academic institutions, hospitals, government  agencies, investors and biopharmaceutical and device companies. He was the co-founder of DecisionLine Clinical Research, a successful translational clinical research company. Dr. Sellers was Vice-President and Director at Clinical Institute of the Addiction Research Foundation, one of the world’s largest and best-known research and treatment organizations in the addiction field. He recently chaired the Scientific Advisory Panel on Opiate Analgesic Abuse for the Therapeutic Products Directorate, Health Canada.